,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1295164,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Kaempferol inhibits the reaction [doxorubicin results in increased phosphorylation of MAPK3 protein],,,PMID:22155320,https://www.ncbi.nlm.nih.gov/pubmed/22155320,22155320.0,,
1,1368941,51605,Comparative Toxicogenomics Database (CTD),Fenoxycarb,C052034,fenoxycarb,https://ctdbase.org/detail.go?type=chem&acc=C052034,35158,SWIP-1,https://ctdbase.org/detail.go?type=gene&acc=35158,,,35158.0,Swip-1,150844.0,Moina macrocopa,Fenoxycarb results in increased expression of SWIP-1 mRNA,,,PMID:31927065,https://www.ncbi.nlm.nih.gov/pubmed/31927065,31927065.0,,
2,1941071,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3759,KCNJ2,https://ctdbase.org/detail.go?type=gene&acc=3759,,,3759.0,KCNJ2,9606.0,Homo sapiens (human),[gasoline results in increased abundance of [particulate matter co-treated with polycyclic aromatic hydrocarbons]] which results in decreased expression of KCNJ2 mrna|[[gasoline co-treated with ethanol] results in increased abundance of [particulate matter co-treated with polycyclic aromatic hydrocarbons]] which results in decreased expression of KCNJ2 mrna|[[gasoline co-treated with 1-butanol] results in increased abundance of [particulate matter co-treated with polycyclic aromatic hydrocarbons]] which results in decreased expression of KCNJ2 mRNA,,,PMID:29432896,https://www.ncbi.nlm.nih.gov/pubmed/29432896,29432896.0,,
3,1941072,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3759,KCNJ2,https://ctdbase.org/detail.go?type=gene&acc=3759,,,3759.0,KCNJ2,9606.0,Homo sapiens (human),Particulate matter results in decreased expression of KCNJ2 mRNA,,,PMID:22178795,https://www.ncbi.nlm.nih.gov/pubmed/22178795,22178795.0,,
4,1941073,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3759,KCNJ2,https://ctdbase.org/detail.go?type=gene&acc=3759,,,3759.0,KCNJ2,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which results in increased expression of KCNJ2 mRNA,,,PMID:32780721,https://www.ncbi.nlm.nih.gov/pubmed/32780721,32780721.0,,
5,1941074,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3759,KCNJ2,https://ctdbase.org/detail.go?type=gene&acc=3759,,,3759.0,KCNJ2,10090.0,Mus musculus (house mouse),Particulate matter results in decreased expression of KCNJ2 mRNA,,,PMID:32873817,https://www.ncbi.nlm.nih.gov/pubmed/32873817,32873817.0,,
6,1941075,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,556073,KCNK13B,https://ctdbase.org/detail.go?type=gene&acc=556073,,,556073.0,kcnk13b,7955.0,Danio rerio (zebrafish),[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of KCNK13B mRNA,,,PMID:34057650,https://www.ncbi.nlm.nih.gov/pubmed/34057650,34057650.0,,
7,1941076,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3777,KCNK3,https://ctdbase.org/detail.go?type=gene&acc=3777,,,3777.0,KCNK3,9606.0,Homo sapiens (human),Particulate matter results in decreased expression of KCNK3 mRNA,,,PMID:22178795,https://www.ncbi.nlm.nih.gov/pubmed/22178795,22178795.0,,
8,1941077,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,8645,KCNK5,https://ctdbase.org/detail.go?type=gene&acc=8645,,,8645.0,KCNK5,10090.0,Mus musculus (house mouse),Particulate matter results in increased expression of KCNK5 mRNA,,,PMID:32873817,https://www.ncbi.nlm.nih.gov/pubmed/32873817,32873817.0,,
9,1941078,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,9424,KCNK6,https://ctdbase.org/detail.go?type=gene&acc=9424,,,9424.0,KCNK6,10116.0,Rattus norvegicus (Norway rat),[oxygen deficiency co-treated with blood glucose deficiency co-treated with particulate matter] results in increased expression of KCNK6 mRNA,,,PMID:33729688,https://www.ncbi.nlm.nih.gov/pubmed/33729688,33729688.0,,
10,1941079,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,51305,KCNK9,https://ctdbase.org/detail.go?type=gene&acc=51305,,,51305.0,KCNK9,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which results in increased expression of KCNK9 mRNA,,,PMID:32579111,https://www.ncbi.nlm.nih.gov/pubmed/32579111,32579111.0,,
11,1941172,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3782,KCNN3,https://ctdbase.org/detail.go?type=gene&acc=3782,,,3782.0,KCNN3,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which affects the expression of KCNN3 mRNA,,,PMID:32636363,https://www.ncbi.nlm.nih.gov/pubmed/32636363,32636363.0,,
12,1941173,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3782,KCNN3,https://ctdbase.org/detail.go?type=gene&acc=3782,,,3782.0,KCNN3,10116.0,Rattus norvegicus (Norway rat),[air pollutants results in increased abundance of particulate matter] which results in decreased expression of KCNN3 mRNA,,,PMID:28106813,https://www.ncbi.nlm.nih.gov/pubmed/28106813,28106813.0,,
13,1941174,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3783,KCNN4,https://ctdbase.org/detail.go?type=gene&acc=3783,,,3783.0,KCNN4,10090.0,Mus musculus (house mouse),[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of KCNN4 mRNA,,,PMID:31568751,https://www.ncbi.nlm.nih.gov/pubmed/31568751,31568751.0,,
14,1941175,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3784,KCNQ1,https://ctdbase.org/detail.go?type=gene&acc=3784,,,3784.0,KCNQ1,9606.0,Homo sapiens (human),KCNQ1 gene SNP affects the susceptibility to [air pollutants results in increased abundance of particulate matter],,,PMID:27281273,https://www.ncbi.nlm.nih.gov/pubmed/27281273,27281273.0,,
15,1941176,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,55539,KCNQ1DN,https://ctdbase.org/detail.go?type=gene&acc=55539,,,55539.0,KCNQ1DN,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of particulate matter] which affects the methylation of KCNQ1DN gene,,,PMID:35835166,https://www.ncbi.nlm.nih.gov/pubmed/35835166,35835166.0,,
16,1941177,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,100507381,KCNQ5-IT1,https://ctdbase.org/detail.go?type=gene&acc=100507381,,,100507381.0,KCNQ5-IT1,9606.0,Homo sapiens (human),Particulate matter results in decreased expression of KCNQ5-IT1 mRNA,,,PMID:32891722,https://www.ncbi.nlm.nih.gov/pubmed/32891722,32891722.0,,
17,1941178,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,3790,KCNS3,https://ctdbase.org/detail.go?type=gene&acc=3790,,,3790.0,KCNS3,10090.0,Mus musculus (house mouse),Particulate matter results in decreased expression of KCNS3 mRNA,,,PMID:36857595,https://www.ncbi.nlm.nih.gov/pubmed/36857595,36857595.0,,
18,1941179,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,57582,KCNT1,https://ctdbase.org/detail.go?type=gene&acc=57582,,,57582.0,KCNT1,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which results in increased expression of KCNT1 mRNA,,,PMID:32579111,https://www.ncbi.nlm.nih.gov/pubmed/32579111,32579111.0,,
19,1941180,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,343450,KCNT2,https://ctdbase.org/detail.go?type=gene&acc=343450,,,343450.0,KCNT2,10090.0,Mus musculus (house mouse),Particulate matter results in decreased expression of KCNT2 mRNA,,,PMID:36857595,https://www.ncbi.nlm.nih.gov/pubmed/36857595,36857595.0,,
20,1941181,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,284252,KCTD1,https://ctdbase.org/detail.go?type=gene&acc=284252,,,284252.0,KCTD1,9606.0,Homo sapiens (human),Particulate matter results in increased expression of KCTD1 mRNA,,,PMID:22178795,https://www.ncbi.nlm.nih.gov/pubmed/22178795,22178795.0,,
21,1941295,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,10945,KDELR1,https://ctdbase.org/detail.go?type=gene&acc=10945,,,10945.0,KDELR1,9606.0,Homo sapiens (human),Particulate matter results in increased expression of KDELR1 mRNA,,,PMID:28412507,https://www.ncbi.nlm.nih.gov/pubmed/28412507,28412507.0,,
22,1941296,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,11015,KDELR3,https://ctdbase.org/detail.go?type=gene&acc=11015,,,11015.0,KDELR3,9606.0,Homo sapiens (human),Particulate matter results in increased expression of KDELR3 mRNA,,,PMID:32891722,https://www.ncbi.nlm.nih.gov/pubmed/32891722,32891722.0,,
23,1941364,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,221656,KDM1B,https://ctdbase.org/detail.go?type=gene&acc=221656,,,221656.0,KDM1B,9606.0,Homo sapiens (human),Particulate matter results in decreased expression of KDM1B mRNA,,,PMID:22178795,https://www.ncbi.nlm.nih.gov/pubmed/22178795,22178795.0,,
24,1941365,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,22992,KDM2A,https://ctdbase.org/detail.go?type=gene&acc=22992,,,22992.0,KDM2A,9606.0,Homo sapiens (human),Acetylcysteine inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] promotes the reaction [KDM2A protein binds to CDKN2A promoter]]|kdm2a protein affects the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of CDKN2A protein]|acetylcysteine inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of KDM2A protein]|[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of KDM2A protein|[vehicle emissions results in increased abundance of particulate matter] promotes the reaction [KDM2A protein binds to TET1 protein]|[vehicle emissions results in increased abundance of particulate matter] promotes the reaction [KDM2A protein binds to CDKN2A promoter]|kdm2a protein affects the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in increased activity of GLB1 protein],,,PMID:31551408,https://www.ncbi.nlm.nih.gov/pubmed/31551408,31551408.0,,
25,1941472,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,321837,KEAP1A,https://ctdbase.org/detail.go?type=gene&acc=321837,,,321837.0,keap1a,7955.0,Danio rerio (zebrafish),[vehicle emissions results in increased abundance of particulate matter] which results in increased expression of KEAP1A mRNA,,,PMID:34057650,https://www.ncbi.nlm.nih.gov/pubmed/34057650,34057650.0,,
26,1941473,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,80759,KHDC1,https://ctdbase.org/detail.go?type=gene&acc=80759,,,80759.0,KHDC1,9606.0,Homo sapiens (human),Particulate matter results in increased expression of KHDC1 mRNA,,,PMID:29703138,https://www.ncbi.nlm.nih.gov/pubmed/29703138,29703138.0,,
27,1941532,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,22889,KHDC4,https://ctdbase.org/detail.go?type=gene&acc=22889,,,22889.0,KHDC4,7955.0,Danio rerio (zebrafish),[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of KHDC4 protein,,,PMID:34057650,https://www.ncbi.nlm.nih.gov/pubmed/34057650,34057650.0,,
28,1941533,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,22889,KHDC4,https://ctdbase.org/detail.go?type=gene&acc=22889,,,22889.0,KHDC4,10090.0,Mus musculus (house mouse),Particulate matter results in decreased expression of KHDC4 mRNA,,,PMID:32873817,https://www.ncbi.nlm.nih.gov/pubmed/32873817,32873817.0,,
29,1941534,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,23351,KHNYN,https://ctdbase.org/detail.go?type=gene&acc=23351,,,23351.0,KHNYN,10090.0,Mus musculus (house mouse),Particulate matter results in decreased expression of KHNYN mRNA,,,PMID:32873817,https://www.ncbi.nlm.nih.gov/pubmed/32873817,32873817.0,,
30,1941535,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,8570,KHSRP,https://ctdbase.org/detail.go?type=gene&acc=8570,,,8570.0,KHSRP,7955.0,Danio rerio (zebrafish),[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of KHSRP protein,,,PMID:34057650,https://www.ncbi.nlm.nih.gov/pubmed/34057650,34057650.0,,
31,1941536,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,8570,KHSRP,https://ctdbase.org/detail.go?type=gene&acc=8570,,,8570.0,KHSRP,10090.0,Mus musculus (house mouse),[air pollutants results in increased abundance of particulate matter] which results in increased expression of KHSRP mRNA,,,PMID:32579111,https://www.ncbi.nlm.nih.gov/pubmed/32579111,32579111.0,,
32,1941537,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,23313,KIAA0930,https://ctdbase.org/detail.go?type=gene&acc=23313,,,23313.0,KIAA0930,9606.0,Homo sapiens (human),[air pollutants results in increased abundance of particulate matter] which affects the methylation of KIAA0930 gene,,,PMID:29935799,https://www.ncbi.nlm.nih.gov/pubmed/29935799,29935799.0,,
33,1941538,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,57179,KIAA1191,https://ctdbase.org/detail.go?type=gene&acc=57179,,,57179.0,KIAA1191,9606.0,Homo sapiens (human),[[vehicle emissions results in increased abundance of air pollutants] which results in increased abundance of particulate matter] which results in increased expression of KIAA1191 mRNA,,,PMID:29980036,https://www.ncbi.nlm.nih.gov/pubmed/29980036,29980036.0,,
34,1941539,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,57670,KIAA1549,https://ctdbase.org/detail.go?type=gene&acc=57670,,,57670.0,KIAA1549,9606.0,Homo sapiens (human),Particulate matter results in increased expression of KIAA1549 mRNA,,,PMID:29703138,https://www.ncbi.nlm.nih.gov/pubmed/29703138,29703138.0,,
35,1941580,9549209,Comparative Toxicogenomics Database (CTD),S-hexanoyl-4'-phosphopantetheine,D052638,Particulate Matter,https://ctdbase.org/detail.go?type=chem&acc=D052638,9585,KIF20B,https://ctdbase.org/detail.go?type=gene&acc=9585,,,9585.0,KIF20B,9606.0,Homo sapiens (human),Particulate matter results in decreased expression of KIF20B mRNA,,,PMID:15046786,https://www.ncbi.nlm.nih.gov/pubmed/15046786,15046786.0,,
36,1941356,9989226,Comparative Toxicogenomics Database (CTD),Aluminum Oxide,D000537,Aluminum Oxide,https://ctdbase.org/detail.go?type=chem&acc=D000537,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9606.0,Homo sapiens (human),Aluminum oxide results in increased expression of FLT1 mRNA,,,PMID:19464052,https://www.ncbi.nlm.nih.gov/pubmed/19464052,19464052.0,,
37,1941357,9989226,Comparative Toxicogenomics Database (CTD),Aluminum Oxide,D000537,Aluminum Oxide,https://ctdbase.org/detail.go?type=chem&acc=D000537,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,9606.0,Homo sapiens (human),Aluminum oxide results in increased expression of FN1 mRNA,,,PMID:19464052,https://www.ncbi.nlm.nih.gov/pubmed/19464052,19464052.0,,
38,1941358,9989226,Comparative Toxicogenomics Database (CTD),Aluminum Oxide,D000537,Aluminum Oxide,https://ctdbase.org/detail.go?type=chem&acc=D000537,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,9606.0,Homo sapiens (human),Aluminum oxide results in decreased expression of FOS mRNA,,,PMID:15585240,https://www.ncbi.nlm.nih.gov/pubmed/15585240,15585240.0,,
39,1941359,9989226,Comparative Toxicogenomics Database (CTD),Aluminum Oxide,D000537,Aluminum Oxide,https://ctdbase.org/detail.go?type=chem&acc=D000537,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,10116.0,Rattus norvegicus (Norway rat),Sesamol inhibits the reaction [aluminum oxide results in increased expression of GSTA1 mrna]|aluminum oxide results in increased expression of GSTA1 mRNA,,,PMID:35403826,https://www.ncbi.nlm.nih.gov/pubmed/35403826,35403826.0,,
40,1941360,9989226,Comparative Toxicogenomics Database (CTD),Aluminum Oxide,D000537,Aluminum Oxide,https://ctdbase.org/detail.go?type=chem&acc=D000537,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,9606.0,Homo sapiens (human),Aluminum oxide results in increased expression of IBSP mRNA,,,PMID:19464052,https://www.ncbi.nlm.nih.gov/pubmed/19464052,19464052.0,,
41,1941361,9989226,Comparative Toxicogenomics Database (CTD),Aluminum Oxide,D000537,Aluminum Oxide,https://ctdbase.org/detail.go?type=chem&acc=D000537,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Aluminum oxide results in increased expression of ICAM1 protein,,,PMID:18456438,https://www.ncbi.nlm.nih.gov/pubmed/18456438,18456438.0,,
42,1941362,9989226,Comparative Toxicogenomics Database (CTD),Aluminum Oxide,D000537,Aluminum Oxide,https://ctdbase.org/detail.go?type=chem&acc=D000537,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9606.0,Homo sapiens (human),Aluminum oxide affects the expression of IGF1 mRNA,,,PMID:19464052,https://www.ncbi.nlm.nih.gov/pubmed/19464052,19464052.0,,
43,1941363,9989226,Comparative Toxicogenomics Database (CTD),Aluminum Oxide,D000537,Aluminum Oxide,https://ctdbase.org/detail.go?type=chem&acc=D000537,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,9606.0,Homo sapiens (human),Aluminum oxide results in increased expression of IL10 mRNA,,,PMID:15183442,https://www.ncbi.nlm.nih.gov/pubmed/15183442,15183442.0,,
44,1941304,9994707,Therapeutic Target Database (TTD),"5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline",D0SG0G,"5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline",https://idrblab.net/ttd/data/drug/details/D0SG0G,T59102,Platelet-derived growth factor receptor beta (PDGFRB),https://idrblab.net/ttd/data/target/details/T59102,P09619,Platelet-derived growth factor receptor beta,5159.0,PDGFRB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
45,1940978,10032468,Comparative Toxicogenomics Database (CTD),Actein,C096064,actein,https://ctdbase.org/detail.go?type=chem&acc=C096064,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10116.0,Rattus norvegicus (Norway rat),Actein results in decreased expression of SCD1 mRNA,,,PMID:19527300,https://www.ncbi.nlm.nih.gov/pubmed/19527300,19527300.0,,
46,1940979,10032468,Comparative Toxicogenomics Database (CTD),Actein,C096064,actein,https://ctdbase.org/detail.go?type=chem&acc=C096064,23753,SDF2L1,https://ctdbase.org/detail.go?type=gene&acc=23753,,,23753.0,SDF2L1,10116.0,Rattus norvegicus (Norway rat),Actein results in increased expression of SDF2L1 protein,,,PMID:29969672,https://www.ncbi.nlm.nih.gov/pubmed/29969672,29969672.0,,
47,1940980,10032468,Comparative Toxicogenomics Database (CTD),Actein,C096064,actein,https://ctdbase.org/detail.go?type=chem&acc=C096064,253512,SLC25A30,https://ctdbase.org/detail.go?type=gene&acc=253512,,,253512.0,SLC25A30,10116.0,Rattus norvegicus (Norway rat),Actein results in decreased expression of SLC25A30 protein,,,PMID:29969672,https://www.ncbi.nlm.nih.gov/pubmed/29969672,29969672.0,,
48,1940981,10032468,Comparative Toxicogenomics Database (CTD),Actein,C096064,actein,https://ctdbase.org/detail.go?type=chem&acc=C096064,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090.0,Mus musculus (house mouse),Actein inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of SOD2 mrna],,,PMID:28836330,https://www.ncbi.nlm.nih.gov/pubmed/28836330,28836330.0,,
49,1940982,10032468,Comparative Toxicogenomics Database (CTD),Actein,C096064,actein,https://ctdbase.org/detail.go?type=chem&acc=C096064,6649,SOD3,https://ctdbase.org/detail.go?type=gene&acc=6649,,,6649.0,SOD3,10090.0,Mus musculus (house mouse),Actein inhibits the reaction [tetrachlorodibenzodioxin results in decreased expression of SOD3 mrna],,,PMID:28836330,https://www.ncbi.nlm.nih.gov/pubmed/28836330,28836330.0,,
50,1940983,10032468,Comparative Toxicogenomics Database (CTD),Actein,C096064,actein,https://ctdbase.org/detail.go?type=chem&acc=C096064,121340,SP7,https://ctdbase.org/detail.go?type=gene&acc=121340,,,121340.0,SP7,10090.0,Mus musculus (house mouse),Actein inhibits the reaction [tetrachlorodibenzodioxin results in decreased expression of SP7 mrna],,,PMID:28836330,https://www.ncbi.nlm.nih.gov/pubmed/28836330,28836330.0,,
51,1940984,10032468,Comparative Toxicogenomics Database (CTD),Actein,C096064,actein,https://ctdbase.org/detail.go?type=chem&acc=C096064,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,10116.0,Rattus norvegicus (Norway rat),Actein results in increased expression of SQLE protein,,,PMID:29969672,https://www.ncbi.nlm.nih.gov/pubmed/29969672,29969672.0,,
52,1941297,10074552,BindingDB,"(3S)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-5-[(2-methylpropyl)sulfanyl]-4-oxopentanoic acid",10662,"(3S)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-5-[(2-methylpropyl)sulfanyl]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10662,1072,Caspase-3,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1072,P42574,Caspase-3,836.0,CASP3,9606.0,Homo sapiens (human),,IC50 (nM),130,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294.0,10.1016/j.bmcl.2003.10.064,
53,1941298,10074552,BindingDB,"(3S)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-5-[(2-methylpropyl)sulfanyl]-4-oxopentanoic acid",10662,"(3S)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-5-[(2-methylpropyl)sulfanyl]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10662,104,Caspase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=104,P29466,Caspase-1,834.0,CASP1,9606.0,Homo sapiens (human),,IC50 (nM),2600,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294.0,10.1016/j.bmcl.2003.10.064,
54,1941299,10074552,BindingDB,"(3S)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-5-[(2-methylpropyl)sulfanyl]-4-oxopentanoic acid",10662,"(3S)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-5-[(2-methylpropyl)sulfanyl]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10662,124,Caspase-8,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=124,Q14790,Caspase-8,841.0,CASP8,9606.0,Homo sapiens (human),,IC50 (nM),7800,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294.0,10.1016/j.bmcl.2003.10.064,
55,1941300,10074552,BindingDB,"(3S)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-5-[(2-methylpropyl)sulfanyl]-4-oxopentanoic acid",10662,"(3S)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-5-[(2-methylpropyl)sulfanyl]-4-oxopentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10662,118,Caspase-7,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=118,P55210,Caspase-7,840.0,CASP7,9606.0,Homo sapiens (human),,IC50 (nM),1800,PMID:14741294|DOI:10.1016/j.bmcl.2003.10.064,https://www.ncbi.nlm.nih.gov/pubmed/14741294|https://doi.org/10.1016/j.bmcl.2003.10.064,14741294.0,10.1016/j.bmcl.2003.10.064,
56,1941301,10075240,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 26",26428,"ethyl (2E)-3-{4-[({8-carbamoyl-7-[(3,5-dimethoxyphenyl)amino]imidazo[1,2-a]pyrimidin-5-yl}amino)methyl]phenyl}prop-2-enoate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26428,759,Tyrosine-protein kinase ZAP-70,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=759,P43403,Tyrosine-protein kinase ZAP-70,7535.0,ZAP70,9606.0,Homo sapiens (human),,IC50 (nM),88,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686.0,10.1016/j.bmc.2008.10.070,
57,1941302,10075240,BindingDB,"Imidazo[1,2-c]pyrimidine-8-carboxamide, 26",26428,"ethyl (2E)-3-{4-[({8-carbamoyl-7-[(3,5-dimethoxyphenyl)amino]imidazo[1,2-a]pyrimidin-5-yl}amino)methyl]phenyl}prop-2-enoate",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26428,763,Tyrosine-protein kinase SYK,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=763,P43405,Tyrosine-protein kinase SYK,6850.0,SYK,9606.0,Homo sapiens (human),,IC50 (nM),>10000,PMID:19010686|DOI:10.1016/j.bmc.2008.10.070,https://www.ncbi.nlm.nih.gov/pubmed/19010686|https://doi.org/10.1016/j.bmc.2008.10.070,19010686.0,10.1016/j.bmc.2008.10.070,
58,1941303,10077147,IUPHAR/BPS Guide to PHARMACOLOGY,N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide,8006,BX-795,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8006,2237,TANK binding kinase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2237,Q9UHD2,Serine/threonine-protein kinase TBK1,29110.0,TBK1,9606.0,Homo sapiens (human),Inhibition,pIC50,8.22,PMID:19307177,https://www.ncbi.nlm.nih.gov/pubmed/19307177,19307177.0,,
59,1941427,10081162,BindingDB,4-(Hydroxymethyl)benzenesulfonamide,10876,4-(hydroxymethyl)benzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10876,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,Ki (nM),55,PMID:16539401|DOI:10.1021/jm0512600,https://www.ncbi.nlm.nih.gov/pubmed/16539401|https://doi.org/10.1021/jm0512600,16539401.0,10.1021/jm0512600,
60,1941428,10081162,BindingDB,4-(Hydroxymethyl)benzenesulfonamide,10876,4-(hydroxymethyl)benzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10876,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,Ki (nM),80,PMID:16539401|DOI:10.1021/jm0512600,https://www.ncbi.nlm.nih.gov/pubmed/16539401|https://doi.org/10.1021/jm0512600,16539401.0,10.1021/jm0512600,
61,1941429,10081162,BindingDB,4-(Hydroxymethyl)benzenesulfonamide,10876,4-(hydroxymethyl)benzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10876,1194,CARBONIC ANHYDRASE,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1194,,,,,,,,Ki (nM),876,PMID:16539401|DOI:10.1021/jm0512600,https://www.ncbi.nlm.nih.gov/pubmed/16539401|https://doi.org/10.1021/jm0512600,16539401.0,10.1021/jm0512600,
62,1941433,10085013,Therapeutic Target Database (TTD),N-(6-phenyl-1H-indazol-3-yl)butyramide,D07PTD,N-(6-phenyl-1H-indazol-3-yl)butyramide,https://idrblab.net/ttd/data/drug/details/D07PTD,T70977,Glycogen synthase kinase-3 beta (GSK-3B),https://idrblab.net/ttd/data/target/details/T70977,P49841,Glycogen synthase kinase-3 beta,2932.0,GSK3B,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
63,1941430,10096344,Drug Gene Interaction database (DGIdb),Linagliptin,,LINAGLIPTIN,https://www.dgidb.org/drugs/rxcui:1100699,,POU2F2,https://www.dgidb.org/genes/hgnc:9213,,,5452.0,POU2F2,9606.0,Homo sapiens (human),,,,,,,,
64,1941431,10097011,BindingDB,3-{[methyl({6-[(9-oxo-9H-xanthen-3-yl)oxy]hexyl})amino]methyl}phenyl N-methylcarbamate,10710,3-{[methyl({6-[(9-oxo-9H-xanthen-3-yl)oxy]hexyl})amino]methyl}phenyl N-methylcarbamate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10710,3619,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3619,P22303,Acetylcholinesterase,43.0,ACHE,9606.0,Homo sapiens (human),,IC50 (nM),1.4,PMID:11689067|DOI:10.1021/jm010914b,https://www.ncbi.nlm.nih.gov/pubmed/11689067|https://doi.org/10.1021/jm010914b,11689067.0,10.1021/jm010914b,
65,1941432,10097011,BindingDB,3-{[methyl({6-[(9-oxo-9H-xanthen-3-yl)oxy]hexyl})amino]methyl}phenyl N-methylcarbamate,10710,3-{[methyl({6-[(9-oxo-9H-xanthen-3-yl)oxy]hexyl})amino]methyl}phenyl N-methylcarbamate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10710,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606.0,Homo sapiens (human),,IC50 (nM),13.9,PMID:11689067|DOI:10.1021/jm010914b,https://www.ncbi.nlm.nih.gov/pubmed/11689067|https://doi.org/10.1021/jm010914b,11689067.0,10.1021/jm010914b,
66,1940985,10127183,BindingDB,"(2S)-N-(cyanomethyl)-2-{[(1S)-1-[4-(4-cyanophenyl)phenyl]-2,2,2-trifluoroethyl]amino}-4-methylpentanamide",19531,"(2S)-N-(cyanomethyl)-2-{[(1S)-1-[4-(4-cyanophenyl)phenyl]-2,2,2-trifluoroethyl]amino}-4-methylpentanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19531,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520.0,CTSS,9606.0,Homo sapiens (human),,IC50 (nM),172,PMID:16413777|DOI:10.1016/j.bmcl.2005.12.071,https://www.ncbi.nlm.nih.gov/pubmed/16413777|https://doi.org/10.1016/j.bmcl.2005.12.071,16413777.0,10.1016/j.bmcl.2005.12.071,
67,1940986,10127622,Chemical Probes Portal,Selumetinib,Selumetinib,Selumetinib,https://www.chemicalprobes.org/selumetinib,,MAP2K1,,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,5604.0,MAP2K1,9606.0,Homo sapiens (human),"Covalent, ATP noncompetitive inhibitor",,14 nM,PMID:17332304,https://www.ncbi.nlm.nih.gov/pubmed/17332304,17332304.0,,"http://clincancerres.aacrjournals.org/content/13/5/1576.long, http://www.ncbi.nlm.nih.gov/pubmed/17332304"
68,1941474,10257882,Drug Gene Interaction database (DGIdb),Sparsentan,,SPARSENTAN,https://www.dgidb.org/drugs/rxcui:2630535,,EDNRA,https://www.dgidb.org/genes/hgnc:3179,,,1909.0,EDNRA,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
69,1941475,10259168,Therapeutic Target Database (TTD),4'' deoxy EM-A enolether,D0M6OV,KOS1326,https://idrblab.net/ttd/data/drug/details/D0M6OV,T62306,Motilin receptor (MLNR),https://idrblab.net/ttd/data/target/details/T62306,O43193,Motilin receptor,2862.0,MLNR,9606.0,Homo sapiens (human),Agonist,,,,,,,
70,1941476,10261158,Comparative Toxicogenomics Database (CTD),"2,2,5,6-Tetramethyl-2,3-dihydropyrazine",C000598211,"3-hydro-2,2,5,6-tetramethylpyrazine",https://ctdbase.org/detail.go?type=chem&acc=C000598211,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),"3-hydro-2,2,5,6-tetramethylpyrazine inhibits the reaction [lipopolysaccharides results in increased expression of CCL2 mrna]",,,PMID:36047112,https://www.ncbi.nlm.nih.gov/pubmed/36047112,36047112.0,,
71,1941477,10261158,Comparative Toxicogenomics Database (CTD),"2,2,5,6-Tetramethyl-2,3-dihydropyrazine",C000598211,"3-hydro-2,2,5,6-tetramethylpyrazine",https://ctdbase.org/detail.go?type=chem&acc=C000598211,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),"3-hydro-2,2,5,6-tetramethylpyrazine inhibits the reaction [lipopolysaccharides results in increased expression of IL6 mrna]",,,PMID:36047112,https://www.ncbi.nlm.nih.gov/pubmed/36047112,36047112.0,,
72,1941478,10261158,Comparative Toxicogenomics Database (CTD),"2,2,5,6-Tetramethyl-2,3-dihydropyrazine",C000598211,"3-hydro-2,2,5,6-tetramethylpyrazine",https://ctdbase.org/detail.go?type=chem&acc=C000598211,4615,MYD88,https://ctdbase.org/detail.go?type=gene&acc=4615,,,4615.0,MYD88,9606.0,Homo sapiens (human),"3-hydro-2,2,5,6-tetramethylpyrazine inhibits the reaction [lipopolysaccharides results in increased expression of MYD88 protein]",,,PMID:32612008,https://www.ncbi.nlm.nih.gov/pubmed/32612008,32612008.0,,
73,1941479,10261158,Comparative Toxicogenomics Database (CTD),"2,2,5,6-Tetramethyl-2,3-dihydropyrazine",C000598211,"3-hydro-2,2,5,6-tetramethylpyrazine",https://ctdbase.org/detail.go?type=chem&acc=C000598211,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,9606.0,Homo sapiens (human),"3-hydro-2,2,5,6-tetramethylpyrazine inhibits the reaction [lipopolysaccharides results in increased phosphorylation of NFKBIA protein]",,,PMID:32612008,https://www.ncbi.nlm.nih.gov/pubmed/32612008,32612008.0,,
74,1941480,10261158,Comparative Toxicogenomics Database (CTD),"2,2,5,6-Tetramethyl-2,3-dihydropyrazine",C000598211,"3-hydro-2,2,5,6-tetramethylpyrazine",https://ctdbase.org/detail.go?type=chem&acc=C000598211,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),"[3-hydro-2,2,5,6-tetramethylpyrazine co-treated with lipopolysaccharides] results in decreased phosphorylation of RELA protein|3-hydro-2,2,5,6-tetramethylpyrazine inhibits the reaction [lipopolysaccharides results in increased expression of and affects the localization of RELA protein]",,,PMID:32612008,https://www.ncbi.nlm.nih.gov/pubmed/32612008,32612008.0,,
75,1941481,10261158,Comparative Toxicogenomics Database (CTD),"2,2,5,6-Tetramethyl-2,3-dihydropyrazine",C000598211,"3-hydro-2,2,5,6-tetramethylpyrazine",https://ctdbase.org/detail.go?type=chem&acc=C000598211,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,9606.0,Homo sapiens (human),"3-hydro-2,2,5,6-tetramethylpyrazine inhibits the reaction [lipopolysaccharides results in increased expression of TLR4 protein]",,,PMID:32612008,https://www.ncbi.nlm.nih.gov/pubmed/32612008,32612008.0,,
76,1941122,10302266,BindingDB,"N-(5-chloro-2H-1,3-benzodioxol-4-yl)-5-(oxan-4-yloxy)-7-[2-(pyridin-4-yloxy)ethoxy]quinazolin-4-amine dihydrochloride",12241,AZD0530 analogue 19,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12241,13,Proto-oncogene tyrosine-protein kinase Src,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=13,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,IC50 (nM),3,PMID:17064066|DOI:10.1021/jm060434q,https://www.ncbi.nlm.nih.gov/pubmed/17064066|https://doi.org/10.1021/jm060434q,17064066.0,10.1021/jm060434q,
77,1941123,10302266,BindingDB,"N-(5-chloro-2H-1,3-benzodioxol-4-yl)-5-(oxan-4-yloxy)-7-[2-(pyridin-4-yloxy)ethoxy]quinazolin-4-amine dihydrochloride",12241,AZD0530 analogue 19,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12241,692,Vascular endothelial growth factor receptor 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=692,P35968,Vascular endothelial growth factor receptor 2,3791.0,KDR,9606.0,Homo sapiens (human),,IC50 (nM),>5000,PMID:17064066|DOI:10.1021/jm060434q,https://www.ncbi.nlm.nih.gov/pubmed/17064066|https://doi.org/10.1021/jm060434q,17064066.0,10.1021/jm060434q,
78,1941124,10311517,BindingDB,P4 alanylamide pyrrolidin-2-one 22,12511,(2S)-2-[(3S)-3-[(6-chloronaphthalene-2-)sulfonamido]-2-oxopyrrolidin-1-yl]-N-(2-cyanoethyl)-N-cyclopentylpropanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12511,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),11,PMID:16982190|DOI:10.1016/j.bmcl.2006.09.001,https://www.ncbi.nlm.nih.gov/pubmed/16982190|https://doi.org/10.1016/j.bmcl.2006.09.001,16982190.0,10.1016/j.bmcl.2006.09.001,
79,1941237,10311669,BindingDB,P4 alanylamide pyrrolidin-2-one 27,12516,(2S)-2-[(3S)-3-[(6-chloronaphthalene-2-)sulfonamido]-2-oxopyrrolidin-1-yl]-N-(propan-2-yl)-N-(pyridin-3-ylmethyl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12516,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),9,PMID:16982190|DOI:10.1016/j.bmcl.2006.09.001,https://www.ncbi.nlm.nih.gov/pubmed/16982190|https://doi.org/10.1016/j.bmcl.2006.09.001,16982190.0,10.1016/j.bmcl.2006.09.001,
80,1941238,10311760,BindingDB,P4 alanylamide pyrrolidin-2-one 50,12540,(2S)-N-(2-aminoethyl)-2-[(3S)-3-{2-[(6-chloronaphthalene-2-)sulfonamido]acetamide}-2-oxopyrrolidin-1-yl]-N-(propan-2-yl)propanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12540,1341,Coagulation factor X,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1341,P00742,Coagulation factor X,2159.0,F10,9606.0,Homo sapiens (human),,Ki (nM),<1,PMID:16982190|DOI:10.1016/j.bmcl.2006.09.001,https://www.ncbi.nlm.nih.gov/pubmed/16982190|https://doi.org/10.1016/j.bmcl.2006.09.001,16982190.0,10.1016/j.bmcl.2006.09.001,
81,1941125,10323013,BindingDB,"Botryllamide B, 2",32619,"Botryllamide B, 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=32619,4026,Broad substrate specificity ATP-binding cassette transporter ABCG2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4026,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),,IC50 (nM),11200,PMID:19555120|DOI:10.1021/cb900134c,https://www.ncbi.nlm.nih.gov/pubmed/19555120|https://doi.org/10.1021/cb900134c,19555120.0,10.1021/cb900134c,
82,1941126,10323571,BindingDB,"3-[(2R,4S,5S,7S)-5-amino-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-2,8-dimethylnonanamido]propanoic acid",18301,"3-[(2R,4S,5S,7S)-5-amino-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-2,8-dimethylnonanamido]propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18301,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),12,PMID:17824679|DOI:10.1021/jm070314y,https://www.ncbi.nlm.nih.gov/pubmed/17824679|https://doi.org/10.1021/jm070314y,17824679.0,10.1021/jm070314y,
83,1941127,10324039,BindingDB,"(2R,4S,5S,7S)-5-amino-N-(2-acetamidoethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-2,8-dimethylnonanamide",18313,"(2R,4S,5S,7S)-5-amino-N-(2-acetamidoethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-2,8-dimethylnonanamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18313,1861,Renin,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1861,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,IC50 (nM),0.3,PMID:17824679|DOI:10.1021/jm070314y,https://www.ncbi.nlm.nih.gov/pubmed/17824679|https://doi.org/10.1021/jm070314y,17824679.0,10.1021/jm070314y,
84,1941128,10324083,Comparative Toxicogenomics Database (CTD),"trans-N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-(1-(2-cyclopentylethyl)piperidin-4-yl)acrylamide",C483241,"N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-(1-(2-cyclopentyl-ethyl)-piperidin-4yl)acrylamide",https://ctdbase.org/detail.go?type=chem&acc=C483241,4887,NPY2R,https://ctdbase.org/detail.go?type=gene&acc=4887,,,4887.0,NPY2R,9606.0,Homo sapiens (human),"N-(1-acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-(1-(2-cyclopentyl-ethyl)-piperidin-4yl)acrylamide binds to and results in decreased activity of NPY2R protein",,,PMID:14617685,https://www.ncbi.nlm.nih.gov/pubmed/14617685,14617685.0,,
85,1941080,10332518,BindingDB,"6,7-Dihydroxy-3-phenylchromen-2-one",86065,DCP,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=86065,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606.0,Homo sapiens (human),,IC50 (nM),246000,PMID:18341250|DOI:10.1080/14756360701404100,https://www.ncbi.nlm.nih.gov/pubmed/18341250|https://doi.org/10.1080/14756360701404100,18341250.0,10.1080/14756360701404100,
86,1941081,10332518,BindingDB,"6,7-Dihydroxy-3-phenylchromen-2-one",86065,DCP,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=86065,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606.0,Homo sapiens (human),,IC50 (nM),124000,PMID:18341250|DOI:10.1080/14756360701404100,https://www.ncbi.nlm.nih.gov/pubmed/18341250|https://doi.org/10.1080/14756360701404100,18341250.0,10.1080/14756360701404100,
87,1941231,10333698,Therapeutic Target Database (TTD),3-Isobutoxy-9H-beta-carboline,D09MYJ,3-Isobutoxy-9H-beta-carboline,https://idrblab.net/ttd/data/drug/details/D09MYJ,T51452,GABA(A) receptor alpha-2 (GABRA2),https://idrblab.net/ttd/data/target/details/T51452,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
88,1941232,10334538,BindingDB,"N-(1,3-benzodioxol-5-ylmethyl)-N-(2-piperidin-1-yl-2-thioxoethyl)amine",12458,"(2H-1,3-benzodioxol-5-ylmethyl)[2-(piperidin-1-yl)-2-sulfanylideneethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12458,5468,Dipeptidyl peptidase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5468,Q9UHL4,Dipeptidyl peptidase 2,29952.0,DPP7,9606.0,Homo sapiens (human),,IC50 (nM),42000,PMID:15771423|DOI:10.1021/jm0495982,https://www.ncbi.nlm.nih.gov/pubmed/15771423|https://doi.org/10.1021/jm0495982,15771423.0,10.1021/jm0495982,
89,1941233,10334538,BindingDB,"N-(1,3-benzodioxol-5-ylmethyl)-N-(2-piperidin-1-yl-2-thioxoethyl)amine",12458,"(2H-1,3-benzodioxol-5-ylmethyl)[2-(piperidin-1-yl)-2-sulfanylideneethyl]amine",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=12458,1234,Dipeptidyl peptidase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1234,P27487,Dipeptidyl peptidase 4,1803.0,DPP4,9606.0,Homo sapiens (human),,IC50 (nM),>1000000,PMID:15771423|DOI:10.1021/jm0495982,https://www.ncbi.nlm.nih.gov/pubmed/15771423|https://doi.org/10.1021/jm0495982,15771423.0,10.1021/jm0495982,
90,1941234,10339600,BindingDB,,25094,"4-[2,4-diamino-7-(3,4-dihydroxyphenyl)pteridin-6-yl]benzene-1,2-diol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25094,2113,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2113,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform ",5294.0,PIK3CG,9606.0,Homo sapiens (human),,IC50 (nM),273,PMID:17685602|DOI:10.1021/jm051056c,https://www.ncbi.nlm.nih.gov/pubmed/17685602|https://doi.org/10.1021/jm051056c,17685602.0,10.1021/jm051056c,
91,1941235,10341154,Drug Gene Interaction database (DGIdb),VX-702,,VX-702,https://www.dgidb.org/drugs/drugbank:DB05470,,MAPK14,https://www.dgidb.org/genes/hgnc:6876,,,1432.0,MAPK14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
92,1941236,10345214,Drug Gene Interaction database (DGIdb),Ronacaleret,,RONACALERET,https://www.dgidb.org/drugs/ncit:C81351,,CASR,https://www.dgidb.org/genes/hgnc:1514,,,846.0,CASR,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
93,1941239,10356247,Therapeutic Target Database (TTD),"Benzo[1,3]dioxol-5-ylmethyl-quinazolin-4-yl-amine",D0O3QI,"Benzo[1,3]dioxol-5-ylmethyl-quinazolin-4-yl-amine",https://idrblab.net/ttd/data/drug/details/D0O3QI,T07663,Phosphodiesterase 5A (PDE5A),https://idrblab.net/ttd/data/target/details/T07663,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",8654.0,PDE5A,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
94,1941240,10363825,BindingDB,"Botryllamide D, 4",32621,"Botryllamide D, 4",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=32621,4026,Broad substrate specificity ATP-binding cassette transporter ABCG2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4026,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),,IC50 (nM),16400,PMID:19555120|DOI:10.1021/cb900134c,https://www.ncbi.nlm.nih.gov/pubmed/19555120|https://doi.org/10.1021/cb900134c,19555120.0,10.1021/cb900134c,
95,1941241,10366136,Drug Gene Interaction database (DGIdb),Crenolanib,,CRENOLANIB,https://www.dgidb.org/drugs/ncit:C64639,,PDGFRB,https://www.dgidb.org/genes/hgnc:8804,,,5159.0,PDGFRB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
96,1985027,11481564,Therapeutic Target Database (TTD),"4-(Phenylsulfanyl)-7H-pyrrolo[2,3-d]pyrimidine",D0M3CT,"4-Phenylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine",https://idrblab.net/ttd/data/drug/details/D0M3CT,T65864,Stress-activated protein kinase 2a (p38 alpha),https://idrblab.net/ttd/data/target/details/T65864,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
97,1985028,11487182,BindingDB,"(2S)-3-[4-(5-methoxy-2-methyl-3-oxo-2,3-dihydropyridazin-4-yl)phenyl]-2-[(2-methylpiperidin-1-yl)carbonylamino]propanoic acid",16826,"(2S)-3-[4-(5-methoxy-2-methyl-3-oxo-2,3-dihydropyridazin-4-yl)phenyl]-2-[(2-methylpiperidin-1-yl)carbonylamino]propanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=16826,174,Integrin alpha-4/beta-1 [T112H],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=174,P13612,Integrin alpha-4,3676.0,ITGA4,9606.0,Homo sapiens (human),,IC50 (nM),1800,PMID:16722660|DOI:10.1021/jm060031q,https://www.ncbi.nlm.nih.gov/pubmed/16722660|https://doi.org/10.1021/jm060031q,16722660.0,10.1021/jm060031q,
98,1985029,11492162,Therapeutic Target Database (TTD),[2-(4-Fluoro-1H-indol-3-yl)-ethyl]-dimethyl-amine,D06ABJ,[2-(4-Fluoro-1H-indol-3-yl)-ethyl]-dimethyl-amine,https://idrblab.net/ttd/data/drug/details/D06ABJ,T83813,5-HT 2C receptor (HTR2C),https://idrblab.net/ttd/data/target/details/T83813,P28335,5-hydroxytryptamine receptor 2C,3358.0,HTR2C,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
99,1941424,11558987,BindingDB,"1,3-Diarylprop-2-yn-1-one, 23b",22365,"1,3-Diarylprop-2-yn-1-one, 23b",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22365,2260,Seed linoleate 13S-lipoxygenase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2260,P08170,Seed linoleate 13S-lipoxygenase-1,547923.0,LOX1.1,3847.0,Glycine max (soybean),,IC50 (nM),300,PMID:16509583|DOI:10.1021/jm0510474,https://www.ncbi.nlm.nih.gov/pubmed/16509583|https://doi.org/10.1021/jm0510474,16509583.0,10.1021/jm0510474,
100,1941425,11559217,BindingDB,"1,3-Diarylprop-2-yn-1-one, 13p",22359,"1,3-Diarylprop-2-yn-1-one, 13p",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22359,2260,Seed linoleate 13S-lipoxygenase-1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2260,P08170,Seed linoleate 13S-lipoxygenase-1,547923.0,LOX1.1,3847.0,Glycine max (soybean),,IC50 (nM),5000,PMID:16509583|DOI:10.1021/jm0510474,https://www.ncbi.nlm.nih.gov/pubmed/16509583|https://doi.org/10.1021/jm0510474,16509583.0,10.1021/jm0510474,
101,1941426,11559217,BindingDB,"1,3-Diarylprop-2-yn-1-one, 13p",22359,"1,3-Diarylprop-2-yn-1-one, 13p",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=22359,2263,Lipoxygenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2263,,,,,,,,IC50 (nM),>10000,PMID:16509583|DOI:10.1021/jm0510474,https://www.ncbi.nlm.nih.gov/pubmed/16509583|https://doi.org/10.1021/jm0510474,16509583.0,10.1021/jm0510474,
102,1941016,11957706,Drug Gene Interaction database (DGIdb),SKF 81297 hydrobromide,,CHEMBL:CHEMBL553503,https://www.dgidb.org/drugs/chembl:CHEMBL553503,,POLI,https://www.dgidb.org/genes/hgnc:9182,,,11201.0,POLI,9606.0,Homo sapiens (human),,,,,,,,
103,1941017,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PALB2,https://www.dgidb.org/genes/hgnc:26144,,,79728.0,PALB2,9606.0,Homo sapiens (human),,,,,,,,
104,1941018,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,PTEN,https://www.dgidb.org/genes/hgnc:9588,,,5728.0,PTEN,9606.0,Homo sapiens (human),,,,,,,,
105,1941019,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,RAD51C,https://www.dgidb.org/genes/hgnc:9820,,,5889.0,RAD51C,9606.0,Homo sapiens (human),,,,,,,,
106,1941020,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,ATM,https://www.dgidb.org/genes/hgnc:795,,,472.0,ATM,9606.0,Homo sapiens (human),,,,,,,,
107,1941021,11960529,Drug Gene Interaction database (DGIdb),Veliparib,,VELIPARIB,https://www.dgidb.org/drugs/ncit:C60768,,ARID1A,https://www.dgidb.org/genes/hgnc:11110,,,8289.0,ARID1A,9606.0,Homo sapiens (human),,,,,,,,
108,1941022,11961293,IUPHAR/BPS Guide to PHARMACOLOGY,Felcisetrag,8426,TD-8954,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8426,9,5-HT4 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=9,Q13639,5-hydroxytryptamine receptor 4,3360.0,HTR4,9606.0,Homo sapiens (human),Agonist,pKi,9.4,PMID:23756062,https://www.ncbi.nlm.nih.gov/pubmed/23756062,23756062.0,,
109,1941023,11963512,DrugBank,N-(trans-4'-Nitro-4-stilbenyl)-N-methyl-5-amino-pentanoic acid,DB08635,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,https://www.drugbank.ca/drugs/DB08635,BE0004312,Immunoglobulin heavy variable 3-30,https://www.drugbank.ca/bio_entities/BE0004312,P01768,Immunoglobulin heavy variable 3-30,,,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235.0,,
110,1941024,11963546,DrugBank,"6-Ethyl-5-[(2s)-1-(3-Methoxypropyl)-2-Phenyl-1,2,3,4-Tetrahydroquinolin-7-Yl]pyrimidine-2,4-Diamine",DB08099,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",https://www.drugbank.ca/drugs/DB08099,BE0000270,Renin,https://www.drugbank.ca/bio_entities/BE0000270,P00797,Renin,5972.0,REN,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235.0,,
111,1941025,11963551,DrugBank,"(5z)-12-Chloro-13,15-Dihydroxy-4,7,8,9-Tetrahydro-2-Benzoxacyclotridecine-1,10(3h,11h)-Dione",DB08292,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",https://www.drugbank.ca/drugs/DB08292,BE0001898,Heat shock protein HSP 90-beta,https://www.drugbank.ca/bio_entities/BE0001898,P08238,Heat shock protein HSP 90-beta,3326.0,HSP90AB1,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235.0,,
112,1941064,16193104,Drug Gene Interaction database (DGIdb),"N-[3-(3,4-dihydroisoquinolin-2(1H)-yl)propyl]-N'-[4-methyl-2-(4-methylpiperazin-1-yl)quinolin-6-yl]thiourea",,CHEMBL:CHEMBL590168,https://www.dgidb.org/drugs/chembl:CHEMBL590168,,RAD54L,https://www.dgidb.org/genes/hgnc:9826,,,8438.0,RAD54L,9606.0,Homo sapiens (human),,,,,,,,
113,1941065,16193104,Drug Gene Interaction database (DGIdb),"N-[3-(3,4-dihydroisoquinolin-2(1H)-yl)propyl]-N'-[4-methyl-2-(4-methylpiperazin-1-yl)quinolin-6-yl]thiourea",,CHEMBL:CHEMBL590168,https://www.dgidb.org/drugs/chembl:CHEMBL590168,,IDH1,https://www.dgidb.org/genes/hgnc:5382,,,3417.0,IDH1,9606.0,Homo sapiens (human),,,,,,,,
114,1985013,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,7182,NR2C2,https://ctdbase.org/detail.go?type=gene&acc=7182,,,7182.0,NR2C2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NR2C2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819.0,,
115,1985014,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,2063,NR2F6,https://ctdbase.org/detail.go?type=gene&acc=2063,,,2063.0,NR2F6,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NR2F6 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819.0,,
116,1985015,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NR3C1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819.0,,
117,1985016,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,2494,NR5A2,https://ctdbase.org/detail.go?type=gene&acc=2494,,,2494.0,NR5A2,10090.0,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of NR5A2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819.0,,
118,1941061,16220188,IUPHAR/BPS Guide to PHARMACOLOGY,Pamapimod,9915,pamapimod,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9915,1499,mitogen-activated protein kinase 14,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1499,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606.0,Homo sapiens (human),Inhibition,pKd,8.89,PMID:21375264,https://www.ncbi.nlm.nih.gov/pubmed/21375264,21375264.0,,
119,1941062,16220188,IUPHAR/BPS Guide to PHARMACOLOGY,Pamapimod,9915,pamapimod,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9915,1496,mitogen-activated protein kinase 8,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1496,P45983,Mitogen-activated protein kinase 8,5599.0,MAPK8,9606.0,Homo sapiens (human),Inhibition,pKd,6.72,PMID:21375264,https://www.ncbi.nlm.nih.gov/pubmed/21375264,21375264.0,,
120,1941063,16220188,IUPHAR/BPS Guide to PHARMACOLOGY,Pamapimod,9915,pamapimod,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9915,1497,mitogen-activated protein kinase 9,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1497,P45984,Mitogen-activated protein kinase 9,5601.0,MAPK9,9606.0,Homo sapiens (human),Inhibition,pKd,7.8,PMID:21375264,https://www.ncbi.nlm.nih.gov/pubmed/21375264,21375264.0,,
121,1941070,16226881,BindingDB,"1-(Chloroacetyl)-4-[(2,6-difluorophenyl)sulfonyl]piperazine",496698,LON-WEI-8f408cad-2,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=496698,1529,Serine protease 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1529,P07477,Trypsin-1,5644.0,PRSS1,9606.0,Homo sapiens (human),,IC50 (nM),99000,,,,,
122,1941066,16654980,Drug Gene Interaction database (DGIdb),Buparlisib,,BUPARLISIB,https://www.dgidb.org/drugs/ncit:C90565,,PIK3R1,https://www.dgidb.org/genes/hgnc:8979,,,5295.0,PIK3R1,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
123,1941067,16654980,Drug Gene Interaction database (DGIdb),Buparlisib,,BUPARLISIB,https://www.dgidb.org/drugs/ncit:C90565,,PIK3R5,https://www.dgidb.org/genes/hgnc:30035,,,23533.0,PIK3R5,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
124,1941068,16654980,Drug Gene Interaction database (DGIdb),Buparlisib,,BUPARLISIB,https://www.dgidb.org/drugs/ncit:C90565,,PIK3CD,https://www.dgidb.org/genes/hgnc:8977,,,5293.0,PIK3CD,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
125,1941069,16654980,Drug Gene Interaction database (DGIdb),Buparlisib,,BUPARLISIB,https://www.dgidb.org/drugs/ncit:C90565,,PIK3CB,https://www.dgidb.org/genes/hgnc:8976,,,5291.0,PIK3CB,9606.0,Homo sapiens (human),Inhibitor,,,,,,,
126,1941129,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,6820,SULT2B1,https://ctdbase.org/detail.go?type=gene&acc=6820,,,6820.0,SULT2B1,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SULT2B1 mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
127,1941130,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,10388,SYCP2,https://ctdbase.org/detail.go?type=gene&acc=10388,,,10388.0,SYCP2,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYCP2 mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
128,1941131,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,81493,SYNC,https://ctdbase.org/detail.go?type=gene&acc=81493,,,81493.0,SYNC,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SYNC mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
129,1941530,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,280664,WFDC10B,https://ctdbase.org/detail.go?type=gene&acc=280664,,,280664.0,WFDC10B,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WFDC10B mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
130,1941531,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,645638,WFDC21P,https://ctdbase.org/detail.go?type=gene&acc=645638,,,645638.0,WFDC21P,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of WFDC21P mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
131,1941581,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,376940,ZC3H6,https://ctdbase.org/detail.go?type=gene&acc=376940,,,376940.0,ZC3H6,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ZC3H6 mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
132,1941582,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,150244,ZDHHC8BP,https://ctdbase.org/detail.go?type=gene&acc=150244,,,150244.0,ZDHHC8BP,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ZDHHC8BP mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
133,1941583,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,7718,ZNF165,https://ctdbase.org/detail.go?type=gene&acc=7718,,,7718.0,ZNF165,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ZNF165 mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
134,1941584,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,100131655,ZNF236-DT,https://ctdbase.org/detail.go?type=gene&acc=100131655,,,100131655.0,ZNF236-DT,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ZNF236-DT mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
135,1941585,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,126069,ZNF491,https://ctdbase.org/detail.go?type=gene&acc=126069,,,126069.0,ZNF491,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ZNF491 mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
136,1941586,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,80032,ZNF556,https://ctdbase.org/detail.go?type=gene&acc=80032,,,80032.0,ZNF556,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ZNF556 mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
137,1941587,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,169270,ZNF596,https://ctdbase.org/detail.go?type=gene&acc=169270,,,169270.0,ZNF596,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ZNF596 mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
138,1941588,16654980,Comparative Toxicogenomics Database (CTD),Buparlisib,C571178,NVP-BKM120,https://ctdbase.org/detail.go?type=chem&acc=C571178,57507,ZNF608,https://ctdbase.org/detail.go?type=gene&acc=57507,,,57507.0,ZNF608,9606.0,Homo sapiens (human),[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ZNF608 mRNA,,,PMID:36139627,https://www.ncbi.nlm.nih.gov/pubmed/36139627,36139627.0,,
